COLL - Collegium Pharm Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 TRCH (0%) SPY (0%) OCGN (0%) MOXC (0%) MGNI (0%) GSAT (0%) GRWG (0%) GOED (0%) GME (0%) FURY (0%) ETSY (0%) ENG (0%) CWH (0%) CRSR (0%) CPE (0%) CELH (0%) BZUN (0%) BFLY (0%) BBIG (0%) BA (0%) AVXL (0%) AU (0%) AMPUSD (%) AMC (0%) ABNB (0%)

COLL - Collegium Pharmaceut...

$23.02 0[0%]

15 mins delayed data

People also watch : HZNP | AOXG | UTHR

+Watchlist

4 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$23.02	Open
Volume		Market Cap	385.78M
Yield		Last Dividend

Day

52 Week

Collegium Pharmaceutical Inc (COLL) fall...	06/22/21
Collegium Pharmaceutical Inc (COLL) falls -1.8060% for June 17 Equities.com

Collegium Announces Publication of Real-...	06/16/21
STOUGHTON, Mass., June 16, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ: COLL ), a specialty pharmaceutical company committed to be...

Needham Releases a Buy Rating on Collegi...	05/28/21
Needham analyst Serge Belanger assigned a Buy rating to Collegium Pharmaceutical (COLL) today and set a price target of $34.00. The post Needham Relea...

Collegium to Participate in Upcoming Inv...	05/19/21
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company committed to being the leader in responsible pain management, announced that manage...

Needham Gives a Buy Rating to Collegium ...	05/14/21
In a report released today, Serge Belanger from Needham assigned a Buy rating to Collegium Pharmaceutical (COLL), with a price target of $34.00. The p...

ANALYST RATINGS

1 analyst ratings (Last 3 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $COLL

Service Name	Trader	% Success
Jess Corner	Jess	79.00 %	Follow
Arbitrage Trade Analytics	Royce Wells	72.00 %	Subscribe
Alpha Swing Trades	Jonathan	68.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%